Recursion Pharmaceuticals (NASDAQ:RXRX) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.05), Briefing.com reports. The firm had revenue of $14.42 million for the quarter, compared to analysts’ expectations of $11.96 million. Recursion Pharmaceuticals had […]
More Stories
Keyence Co. (OTCMKTS:KYCCF) Sees Significant Decrease in Short Interest
Keyence Co. (OTCMKTS:KYCCF – Get Free Report) was the target of a large drop in short interest during the month...
EnLink Midstream (NYSE:ENLC) Lowered to “Equal Weight” at Morgan Stanley
Morgan Stanley cut shares of EnLink Midstream (NYSE:ENLC – Free Report) from an overweight rating to an equal weight rating...
HC Wainwright Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON)
HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released...
DMC Global (NASDAQ:BOOM) PT Lowered to $17.00 at Stifel Nicolaus
DMC Global (NASDAQ:BOOM – Free Report) had its target price decreased by Stifel Nicolaus from $19.00 to $17.00 in a...
Cellectar Biosciences (NASDAQ:CLRB) Upgraded at StockNews.com
StockNews.com upgraded shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) to a sell rating in a research report sent to...
Conn’s (NASDAQ:CONN) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Conn’s (NASDAQ:CONN – Free Report) in a research note released on Tuesday morning. The...